Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Jepson

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Risk Analysis : an Official Publication of the Society for Risk Analysis|March 15, 2003
Incremental and average cost-effectiveness ratios: will physicians make a distinction?John C Hershey, David A Asch, Christopher Jepson, et al.
Social Science & Medicine (1982)|March 18, 2003
The influence of cost-effectiveness information on physicians' cancer screening recommendationsPeter A Ubel, Christopher Jepson, Jonathan Baron, et al.
Journal of Experimental Psychology. General|February 11, 2005
Ignorance of hedonic adaptation to hemodialysis: a study using ecological momentary assessmentJason Riis, George Loewenstein, Jonathan Baron, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 30, 2014
Effects of tailored risk communications for skin cancer prevention and detection: the PennSCAPE randomized trialKaren Glanz, Kathryn Volpicelli, Christopher Jepson, et al.
Drug and Alcohol Dependence|June 8, 2013
No untoward effects of smoking cues in anti-smoking public service announcementsMary Falcone, Caryn Lerman, Joseph N Cappella, et al.
Psychopharmacology|February 1, 2005
Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigmMargaret Rukstalis, Christopher Jepson, Andrew Strasser, et al.
Drug and Alcohol Dependence|November 26, 2003
Predictors of attendance in a randomized clinical trial of nicotine replacement therapy with behavioral counselingFreda Patterson, Christopher Jepson, Vyga Kaufmann, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2007
CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapyAnna M Lee, Christopher Jepson, Peter G Shields, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 20, 2004
The validity of person tradeoff measurements: randomized trial of computer elicitation versus face-to-face interviewLaura J Damschroder, Jonathan Baron, John C Hershey, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2003
Individual differences in nicotine intake per cigaretteFreda Patterson, Neal Benowitz, Peter Shields, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Risk Analysis : an Official Publication of the Society for Risk Analysis|March 15, 2003
Incremental and average cost-effectiveness ratios: will physicians make a distinction?John C Hershey, David A Asch, Christopher Jepson, et al.
Social Science & Medicine (1982)|March 18, 2003
The influence of cost-effectiveness information on physicians' cancer screening recommendationsPeter A Ubel, Christopher Jepson, Jonathan Baron, et al.
Journal of Experimental Psychology. General|February 11, 2005
Ignorance of hedonic adaptation to hemodialysis: a study using ecological momentary assessmentJason Riis, George Loewenstein, Jonathan Baron, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 30, 2014
Effects of tailored risk communications for skin cancer prevention and detection: the PennSCAPE randomized trialKaren Glanz, Kathryn Volpicelli, Christopher Jepson, et al.
Drug and Alcohol Dependence|June 8, 2013
No untoward effects of smoking cues in anti-smoking public service announcementsMary Falcone, Caryn Lerman, Joseph N Cappella, et al.
Psychopharmacology|February 1, 2005
Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigmMargaret Rukstalis, Christopher Jepson, Andrew Strasser, et al.
Drug and Alcohol Dependence|November 26, 2003
Predictors of attendance in a randomized clinical trial of nicotine replacement therapy with behavioral counselingFreda Patterson, Christopher Jepson, Vyga Kaufmann, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2007
CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapyAnna M Lee, Christopher Jepson, Peter G Shields, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 20, 2004
The validity of person tradeoff measurements: randomized trial of computer elicitation versus face-to-face interviewLaura J Damschroder, Jonathan Baron, John C Hershey, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2003
Individual differences in nicotine intake per cigaretteFreda Patterson, Neal Benowitz, Peter Shields, et al.
Pageof 5